Amalia Gastaldelli
Amalia Gastaldelli
Institute of Clinical Physiology
Email verificata su ifc.cnr.it
Titolo
Citata da
Citata da
Anno
Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration
JA Romijn, EF Coyle, LS Sidossis, A Gastaldelli, JF Horowitz, E Endert, ...
American Journal of Physiology-Endocrinology And Metabolism 265 (3), E380-E391, 1993
20041993
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
R Belfort, SA Harrison, K Brown, C Darland, J Finch, J Hardies, B Balas, ...
New England Journal of Medicine 355 (22), 2297-2307, 2006
16562006
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi, A Gastaldelli, E Vanni, R Gambino, M Cassader, S Baldi, ...
Diabetologia 48 (4), 634-642, 2005
6702005
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ...
Obesity Facts 9 (2), 65-90, 2016
6362016
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.
EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ...
DIABETOLOGIA 59 (6), 1148-9, 2016
636*2016
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
EASL, G Marchesini, CP Day, JF Dufour, A Canbay, V Nobili, V Ratziu, ...
J Hepatol 64 (6), 1388-402, 2016
636*2016
A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes
S Kashyap, R Belfort, A Gastaldelli, T Pratipanawatr, R Berria, ...
Diabetes 52 (10), 2461-2474, 2003
5972003
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
M Gaggini, M Morelli, E Buzzigoli, RA DeFronzo, E Bugianesi, ...
Nutrients 5 (5), 1544-1560, 2013
5822013
β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis
E Ferrannini, A Gastaldelli, Y Miyazaki, M Matsuda, A Mari, RA DeFronzo
The Journal of Clinical Endocrinology & Metabolism 90 (1), 493-500, 2005
5412005
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects
A Gastaldelli, K Cusi, M Pettiti, J Hardies, Y Miyazaki, R Berria, ...
Gastroenterology 133 (2), 496-506, 2007
5262007
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi, U Pagotto, R Manini, E Vanni, A Gastaldelli, R de Iasio, ...
The journal of clinical endocrinology & metabolism 90 (6), 3498-3504, 2005
4622005
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
F Marra, A Gastaldelli, GS Baroni, G Tell, C Tiribelli
Trends in molecular medicine 14 (2), 72-81, 2008
4262008
Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients
E Muscelli, A Mari, A Casolaro, S Camastra, G Seghieri, A Gastaldelli, ...
Diabetes 57 (5), 1340-1348, 2008
3942008
Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
A Gastaldelli, M Kozakova, K Hjlund, A Flyvbjerg, A Favuzzi, A Mitrakou, ...
Hepatology 49 (5), 1537-1544, 2009
3662009
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study
A Gastaldelli, E Ferrannini, Y Miyazaki, M Matsuda, RA DeFronzo
Diabetologia 47 (1), 31-39, 2004
3532004
Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.
A Gastaldelli, S Baldi, M Pettiti, E Toschi, S Camastra, A Natali, ...
Diabetes 49 (8), 1367-1373, 2000
3272000
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
G Svegliati‐Baroni, S Saccomanno, C Rychlicki, L Agostinelli, ...
Liver International 31 (9), 1285-1297, 2011
3142011
Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
A Mari, O Schmitz, A Gastaldelli, T Oestergaard, B Nyholm, E Ferrannini
American Journal of Physiology-Endocrinology and Metabolism 283 (6), E1159-E1166, 2002
3052002
Visceral fat in hypertension: influence on insulin resistance and β-cell function
AM Sironi, A Gastaldelli, A Mari, D Ciociaro, V Postano, E Buzzigoli, ...
Hypertension 44 (2), 127-133, 2004
2982004
Acute effects of gastric bypass versus gastric restrictive surgery on β-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes
SR Kashyap, S Daud, KR Kelly, A Gastaldelli, H Win, S Brethauer, ...
International journal of obesity 34 (3), 462-471, 2010
2972010
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20